Literature DB >> 16373425

Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice.

Robert W Freel1, Marguerite Hatch, Mike Green, Manoocher Soleimani.   

Abstract

Intestinal oxalate transport, mediated by anion exchange proteins, is important to oxalate homeostasis and consequently to calcium oxalate stone diseases. To assess the contribution of the putative anion transporter (PAT)1 (Slc26a6) to transepithelial oxalate transport, we compared the unidirectional and net fluxes of oxalate across isolated, short-circuited segments of the distal ileum of wild-type (WT) mice and Slc26a6 null mice [knockout (KO)]. Additionally, urinary oxalate excretion was measured in both groups. In WT mouse ileum, there was a small net secretion of oxalate (J(net)(Ox) = -5.0 +/-5.0 pmol.cm(-2).h(-1)), whereas in KO mice J(net)(Ox) was significantly absorptive (75 +/- 10 pmol.cm(-2)h.h(-1)), which was the result of a smaller serosal-to-mucosal oxalate flux (J(sm)(Ox)) and a larger mucosal-to-serosal oxalate flux (J(ms)(Ox)). Mucosal DIDS (200 microM) reduced J(sm)(Ox) in WT mice, leading to reversal of the direction of net oxalate transport from secretion to absorption (J(net)(Ox) = 15.0 +/- 5.0 pmol.cm(-2).h(-1)) , but DIDS had no significant effect on KO ileum. In WT mice in the absence of mucosal Cl(-), there were small increases in J(ms)(Ox) and decreases in J(sm)(Ox) that led to a small net oxalate absorption. In KO mice, J(net)(Ox) was 1.5-fold greater in the absence of mucosal Cl(-), due solely to an increase in J(ms)(Ox). Urinary oxalate excretion was about fourfold greater in KO mice compared with WT littermates. We conclude that PAT1 is DIDS sensitive and mediates a significant fraction of oxalate efflux across the apical membrane in exchange for Cl(-); as such, PAT1 represents a major apical membrane pathway mediating J(sm)(Ox).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373425     DOI: 10.1152/ajpgi.00481.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  80 in total

1.  SNPs of metabolism, not stones.

Authors:  Michael F Romero
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

2.  Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells.

Authors:  Hatim A Hassan; Ming Cheng; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

3.  Parsing apical oxalate exchange in Caco-2BBe1 monolayers: siRNA knockdown of SLC26A6 reveals the role and properties of PAT-1.

Authors:  Robert W Freel; Makoto Morozumi; Marguerite Hatch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

4.  Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model.

Authors:  Isabel Garcia-Perez; Alma Villaseñor; Anisha Wijeyesekera; Joram M Posma; Zhirong Jiang; Jeremiah Stamler; Peter Aronson; Robert Unwin; Coral Barbas; Paul Elliott; Jeremy Nicholson; Elaine Holmes
Journal:  J Proteome Res       Date:  2012-08-28       Impact factor: 4.466

5.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

Review 6.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

7.  Variability of Oxalobacter formigenes and oxalate in stool samples.

Authors:  Sergey Prokopovich; John Knight; Dean G Assimos; Ross P Holmes
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

8.  Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.

Authors:  Carla G Monico; Adam Weinstein; Zhirong Jiang; Audrey L Rohlinger; Andrea G Cogal; Beth B Bjornson; Julie B Olson; Eric J Bergstralh; Dawn S Milliner; Peter S Aronson
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

9.  Enteric oxalate secretion is not directly mediated by the human CFTR chloride channel.

Authors:  Robert W Freel; Marguerite Hatch
Journal:  Urol Res       Date:  2008-06-18

Review 10.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.